Tag Archives: biotechnology
AI, Energy and Everything in Between: Thematics in July 2025
Building on the launch of the inaugural S&P Thematics Dashboard, the July edition analyzes the monthly performance of a broad set of themes to uncover key market dynamics. Designed as a thematic market lens, the dashboard—developed in collaboration with Theia Insights—offers rich perspectives on market performance by leveraging nearly 200 themes shaping the global economy….
- Categories Thematics
- Other Tags
- Categories
- Thematics
- Other Tags
S&P SmallCap 600: A Pandemic Case Study
Index construction matters when seeking to understand differences in index characteristics and any resulting divergences in index performance. One of the clearest examples of the importance of index construction comes when comparing the S&P SmallCap 600® and the Russell 2000. Indeed, while both indices are designed to measure the performance of the small-cap U.S. equity…
- Categories Equities
- Other Tags
What’s In A Sector?
Following an index announcement stating Nektar (NKTR) among other stocks would be moving to the S&P 500 prior to the open on March 19, 2018, an inquiry came in about the index impact of NKTR on the S&P SmallCap 600 Health Care Index performance. Given the stock rose over 70% in 2018, it seemed reasonable to…
- Categories Equities, S&P 500 & DJIA
- Other Tags
Biotech Has More Room to Run
Biotechnology has been one of the best performing industries in the stock market over the past several years. According to S&P Capital IQ, there were numerous catalysts, for this substantial stock outperformance, including several blockbuster drug approvals that drove significant sales and earnings growth. Yet, S&P CIQ thinks the industry’s drivers, including a robust pipeline,…
- Categories Equities
- Other Tags
- Categories
- Equities
- Other Tags